Beta Bionics (BBNX) Inventory (2023 - 2026)

Beta Bionics' Inventory history runs 4 years deep, the most recent figure standing at $23.7 million for Q1 2026.

• In Q1 2026, Inventory rose 50.84% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $23.7 million (up 50.84% YoY), while the FY2025 annual figure was $21.7 million, up 63.08% from the prior year.
• Inventory came in at $23.7 million for Q1 2026 at Beta Bionics, up from $21.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.7 million in Q1 2026 to a low of $1.2 million in Q4 2023.
• A 4-year average of $16.2 million and a median of $17.3 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 969.88% in 2024 and jumped 50.84% in 2026, its largest moves.
• Beta Bionics' Inventory stood at $1.2 million in 2023, then jumped by 969.88% to $13.3 million in 2024, then soared by 63.08% to $21.7 million in 2025, then rose by 9.23% to $23.7 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $23.7 million, $21.7 million, and $20.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison